For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
As of close of business last night, TG Therapeutics Inc’s stock clocked out at $31.44, down -3.34% from its previous closing price of $32.53. In other words, the price has decreased by -$3.34 from its previous closing price. On the day, 1.56 million shares were traded. TGTX stock price reached its highest trading level at $32.3 during the session, while it also had its lowest trading level at $31.225.
Ratios:
To gain a deeper understanding of TGTX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.91 and its Current Ratio is at 4.59. In the meantime, Its Debt-to-Equity ratio is 1.32 whereas as Long-Term Debt/Eq ratio is at 1.31.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, TD Cowen on October 29, 2024, initiated with a Buy rating and assigned the stock a target price of $50.
On August 02, 2023, Goldman Upgraded its rating to Neutral which previously was Sell and also lowered its target price recommendation from $16 to $12.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 11 ’24 when Lonial Sagar sold 5,000 shares for $30.44 per share. The transaction valued at 152,200 led to the insider holds 100,195 shares of the business.
Charney Laurence N sold 25,000 shares of TGTX for $754,875 on Nov 11 ’24. The Director now owns 212,479 shares after completing the transaction at $30.20 per share. On Nov 11 ’24, another insider, Charney Laurence N, who serves as the Director of the company, bought 25,000 shares for $30.19 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TGTX now has a Market Capitalization of 4894885376 and an Enterprise Value of 4426240512. For the stock, the TTM Price-to-Sale (P/S) ratio is 17.95 while its Price-to-Book (P/B) ratio in mrq is 25.49. Its current Enterprise Value per Revenue stands at 16.716 whereas that against EBITDA is -10848.629.
Stock Price History:
Over the past 52 weeks, TGTX has reached a high of $36.84, while it has fallen to a 52-week low of $12.84. The 50-Day Moving Average of the stock is 3.98%, while the 200-Day Moving Average is calculated to be 44.14%.
Shares Statistics:
It appears that TGTX traded 2.90M shares on average per day over the past three months and 1975390 shares per day over the past ten days. A total of 155.78M shares are outstanding, with a floating share count of 140.50M. Insiders hold about 9.74% of the company’s shares, while institutions hold 65.43% stake in the company. Shares short for TGTX as of 1734048000 were 27139751 with a Short Ratio of 9.36, compared to 1731628800 on 28328140. Therefore, it implies a Short% of Shares Outstanding of 27139751 and a Short% of Float of 19.259999999999998.
